Market Overview
The Antibody-drug Conjugates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Antibody-drug Conjugates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 3049.2 million by 2025, from USD 2722.8 million in 2019.
Market segmentation
Antibody-drug Conjugates market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Antibody-drug Conjugates market has been segmented into Adcetris, Kadcyla, etc.
Breakdown by Application, Antibody-drug Conjugates has been segmented into Breast Cancer, Lymphoma, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody-drug Conjugates market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody-drug Conjugates markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody-drug Conjugates market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Antibody-drug Conjugates Market Share Analysis
Antibody-drug Conjugates competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Antibody-drug Conjugates sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody-drug Conjugates sales, revenue and market share for each player covered in this report.
The major players covered in Antibody-drug Conjugates are: ImmunoGen, Takeda, Seattle Genetics, Roche, etc. Among other players domestic and global, Antibody-drug Conjugates market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Antibody-drug Conjugates market are listed below:
ImmunoGen
Takeda
Seattle Genetics
Roche
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Adcetris
Kadcyla
Market segment by Application, can be divided into
Breast Cancer
Lymphoma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Antibody-drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugates Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugates Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size and Forecast (2015-2025)
1.4.1 Global Antibody-drug Conjugates Revenue and Forecast (2015-2025)
1.4.2 Global Antibody-drug Conjugates Sales and Forecast (2015-2025)
1.5 Global Antibody-drug Conjugates Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business
2.1.3 ImmunoGen SWOT Analysis
2.1.4 ImmunoGen Product and Services
2.1.5 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Seattle Genetics
2.3.1 Seattle Genetics Details
2.3.2 Seattle Genetics Major Business
2.3.3 Seattle Genetics SWOT Analysis
2.3.4 Seattle Genetics Product and Services
2.3.5 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Antibody-drug Conjugates Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Antibody-drug Conjugates Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Antibody-drug Conjugates Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Antibody-drug Conjugates Sales in United States (2018-2019)
3.2.2 United States Antibody-drug Conjugates Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2019
3.3.2 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Antibody-drug Conjugates Market Size by Geography (2015-2020)
4.1.1 Global Antibody-drug Conjugates Sales by Geography (2015-2020)
4.1.2 Global Antibody-drug Conjugates Revenue by Regions (2015-2020)
4.2 Global Antibody-drug Conjugates Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Antibody-drug Conjugates Sales and Forecast by Regions (2020-2025)
4.2.2 Global Antibody-drug Conjugates Revenue and Forecast by Regions (2020-2025)
4.3 North America Antibody-drug Conjugates Market Size and Forecast (2015-2025)
4.4 Europe Antibody-drug Conjugates Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Antibody-drug Conjugates Market Size and Forecast (2015-2025)
4.6 South America Antibody-drug Conjugates Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Antibody-drug Conjugates Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Antibody-drug Conjugates Market Size by Country (2015-2020)
5.1.1 North America Antibody-drug Conjugates Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugates Revenue and Market Share by Country (2015-2020)
5.2 North America Antibody-drug Conjugates Market Size and Forecast by Country (2020-2025)
5.2.1 North America Antibody-drug Conjugates Sales and Forecast by Country (2020-2025)
5.2.2 North America Antibody-drug Conjugates Revenue and Forecast by Country (2020-2025)
5.3 United States Antibody-drug Conjugates Market Size and Forecast (2015-2025)
5.4 Canada Antibody-drug Conjugates Market Size and Forecast (2015-2025)
5.5 Mexico Antibody-drug Conjugates Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Antibody-drug Conjugates Market Size by Country (2015-2020)
6.1.1 Europe Antibody-drug Conjugates Sales by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugates Revenue by Country (2015-2020)
6.2 Europe Antibody-drug Conjugates Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Antibody-drug Conjugates Sales and Forecast by Country (2020-2025)
6.2.2 Europe Antibody-drug Conjugates Revenue and Forecast by Country (2020-2025)
6.3 Germany Antibody-drug Conjugates Market Size and Forecast (2015-2025)
6.4 United Kingdom Antibody-drug Conjugates Market Size and Forecast (2015-2025)
6.5 France Antibody-drug Conjugates Market Size and Forecast (2015-2025)
6.6 Russia Antibody-drug Conjugates Market Size and Forecast (2015-2025)
6.7 Italy Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibody-drug Conjugates Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Antibody-drug Conjugates Sales by Region (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugates Revenue by Region (2015-2020)
7.2 Asia-Pacific Antibody-drug Conjugates Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Antibody-drug Conjugates Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Antibody-drug Conjugates Revenue and Forecast by Region (2020-2025)
7.3 China Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7.4 Japan Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7.5 Korea Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7.6 India Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7.7 Southeast Asia Antibody-drug Conjugates Market Size and Forecast (2015-2025)
7.8 Australia Antibody-drug Conjugates Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Antibody-drug Conjugates Market Size by Country (2015-2020)
8.1.1 South America Antibody-drug Conjugates Sales by Country (2015-2020)
8.1.2 South America Antibody-drug Conjugates Revenue by Country (2015-2020)
8.2 South America Antibody-drug Conjugates Market Size and Forecast by Country (2020-2025)
8.2.1 South America Antibody-drug Conjugates Sales and Forecast by Country (2020-2025)
8.2.2 South America Antibody-drug Conjugates Revenue and Forecast by Country (2020-2025)
8.3 Brazil Antibody-drug Conjugates Market Size and Forecast (2015-2025)
8.4 Argentina Antibody-drug Conjugates Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibody-drug Conjugates Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Antibody-drug Conjugates Sales by Country (2015-2020)
9.1.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2015-2020)
9.2 Middle East & Africa Antibody-drug Conjugates Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Antibody-drug Conjugates Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Antibody-drug Conjugates Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Antibody-drug Conjugates Market Size and Forecast (2015-2025)
9.4 Turkey Antibody-drug Conjugates Market Size and Forecast (2015-2025)
9.5 Egypt Antibody-drug Conjugates Market Size and Forecast (2015-2025)
9.6 South Africa Antibody-drug Conjugates Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Antibody-drug Conjugates Market Size by Type (2015-2020)
10.1.1 Global Antibody-drug Conjugates Sales by Type (2015-2020)
10.1.2 Global Antibody-drug Conjugates Revenue by Type (2015-2020)
10.1.3 Global Antibody-drug Conjugates Price by Type (2015-2020)
10.2 Global Antibody-drug Conjugates Market Size and Forecast by Type (2020-2025)
10.2.1 Global Antibody-drug Conjugates Sales and Forecast by Type (2020-2025)
10.2.2 Global Antibody-drug Conjugates Revenue and Forecast by Type (2020-2025)
10.2.3 Global Antibody-drug Conjugates Price and Forecast by Type (2020-2025)
10.3 United States Antibody-drug Conjugates Market Size and Forecast by Type (2015-2025)
10.3.1 United States Antibody-drug Conjugates Market Size by Type (2015-2020)
10.3.2 United States Antibody-drug Conjugates Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Antibody-drug Conjugates Market Size by Application (2015-2020)
11.1.1 Global Antibody-drug Conjugates Sales by Application (2015-2020)
11.1.2 Global Antibody-drug Conjugates Revenue by Application (2015-2020)
11.1.3 Global Antibody-drug Conjugates Price by Application (2015-2020)
11.2 Global Antibody-drug Conjugates Market Size and Forecast by Application (2020-2025)
11.2.1 Global Antibody-drug Conjugates Sales and Forecast by Application (2020-2025)
11.2.2 Global Antibody-drug Conjugates Revenue and Forecast by Application (2020-2025)
11.2.3 Global Antibody-drug Conjugates Price and Forecast by Application (2020-2025)
11.3 United States Antibody-drug Conjugates Market Size and Forecast by Application (2015-2025)
11.3.1 United States Antibody-drug Conjugates Market Size by Application (2015-2020)
11.3.2 United States Antibody-drug Conjugates Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Antibody-drug Conjugates Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody-drug Conjugates Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Antibody-drug Conjugates Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Antibody-drug Conjugates Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 7. ImmunoGen Antibody-drug Conjugates Major Business
Table 8. ImmunoGen Antibody-drug Conjugates Total Revenue (USD Million) (2018-2019)
Table 9. ImmunoGen SWOT Analysis
Table 10. ImmunoGen Antibody-drug Conjugates Product and Services
Table 11. ImmunoGen Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. Takeda Basic Information, Manufacturing Base and Competitors
Table 13. Takeda Antibody-drug Conjugates Major Business
Table 14. Takeda Antibody-drug Conjugates Total Revenue (USD Million) (2018-2019)
Table 15. Takeda SWOT Analysis
Table 16. Takeda Antibody-drug Conjugates Product and Services
Table 17. Takeda Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 19. Seattle Genetics Antibody-drug Conjugates Major Business
Table 20. Seattle Genetics Antibody-drug Conjugates Total Revenue (USD Million) (2018-2019)
Table 21. Seattle Genetics SWOT Analysis
Table 22. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 23. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Roche Basic Information, Manufacturing Base and Competitors
Table 25. Roche Antibody-drug Conjugates Major Business
Table 26. Roche Antibody-drug Conjugates Total Revenue (USD Million) (2018-2019)
Table 27. Roche SWOT Analysis
Table 28. Roche Antibody-drug Conjugates Product and Services
Table 29. Roche Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. Global Antibody-drug Conjugates Sales by Manufacturer (2018-2019) (Kg)
Table 31. Global Antibody-drug Conjugates Revenue by Manufacturer (2018-2019) (USD Million)
Table 32. Key Players Antibody-drug Conjugates Sales in United States (2018-2019) (Kg)
Table 33. Key Players Antibody-drug Conjugates Sales Market Share in United States (2018-2019)
Table 34. Key Players Revenue of Antibody-drug Conjugates in United States (2018-2019) (USD Million)
Table 35. Global Antibody-drug Conjugates Sales by Regions (2015-2020) (Kg)
Table 36. Global Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 37. Global Antibody-drug Conjugates Revenue by Regions (2015-2020) (USD Million)
Table 38. Global Antibody-drug Conjugates Sales and Forecast by Regions (2020-2025) (Kg)
Table 39. Global Antibody-drug Conjugates Sales Market Share by Regions (2020-2025)
Table 40. Global Antibody-drug Conjugates Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 41. Global Antibody-drug Conjugates Revenue Market Share by Regions (2020-2025) (USD Million)
Table 42. North America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 43. North America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 44. North America Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 46. North America Antibody-drug Conjugates Sales by Country (2020-2025) (Kg)
Table 47. North America Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 48. North America Antibody-drug Conjugates Revenue by Country (2020-2025) (USD Million)
Table 49. North America Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 50. Europe Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 52. Europe Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 53. Europe Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 54. Europe Antibody-drug Conjugates Sales by Country (2020-2025) (Kg)
Table 55. Europe Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 56. Europe Antibody-drug Conjugates Revenue by Country (2020-2025) (USD Million)
Table 57. Europe Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 58. Asia-Pacific Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 59. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 60. Asia-Pacific Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 62. Asia-Pacific Antibody-drug Conjugates Sales by Country (2020-2025) (Kg)
Table 63. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 64. Asia-Pacific Antibody-drug Conjugates Revenue by Country (2020-2025) (USD Million)
Table 65. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 66. South America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 67. South America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 68. South America Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 69. South America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 70. South America Antibody-drug Conjugates Sales by Country (2020-2025) (Kg)
Table 71. South America Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 72. South America Antibody-drug Conjugates Revenue by Country (2020-2025) (USD Million)
Table 73. South America Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 74. Middle East & Africa Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 75. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 78. Middle East & Africa Antibody-drug Conjugates Sales by Country (2020-2025) (Kg)
Table 79. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Country (2020-2025)
Table 80. Middle East & Africa Antibody-drug Conjugates Revenue by Country (2020-2025) (USD Million)
Table 81. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Country (2020-2025)
Table 82. United States Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 83. United States Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 84. United States Antibody-drug Conjugates Revenue by Type (2015-2020) (USD Million)
Table 85. United States Antibody-drug Conjugates Revenue Market Share by Type (2015-2020)
Table 86. United States Antibody-drug Conjugates Sales by Type (2020-2025) (Kg)
Table 87. United States Antibody-drug Conjugates Sales Market Share by Type (2020-2025)
Table 88. United States Antibody-drug Conjugates Revenue by Type (2020-2025) (USD Million)
Table 89. United States Antibody-drug Conjugates Revenue Market Share by Type (2020-2025)
Table 90. Global Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 91. Global Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 92. Global Antibody-drug Conjugates Revenue by Application (2015-2020) (USD Million)
Table 93. Global Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
Table 94. Global Antibody-drug Conjugates Price by Application (2015-2020) (USD/Kg)
Table 95. Global Antibody-drug Conjugates Sales by Application (2020-2025) (Kg)
Table 96. Global Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 97. Global Antibody-drug Conjugates Revenue by Application (2020-2025) (USD Million)
Table 98. Global Antibody-drug Conjugates Revenue Market Share by Application (2020-2025)
Table 99. Global Antibody-drug Conjugates Price by Application (2020-2025) (USD/Kg)
Table 100. United States Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 101. United States Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 102. United States Antibody-drug Conjugates Revenue by Application (2015-2020) (USD Million)
Table 103. United States Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
Table 104. United States Antibody-drug Conjugates Sales by Application (2020-2025) (Kg)
Table 105. United States Antibody-drug Conjugates Sales Market Share by Application (2020-2025)
Table 106. United States Antibody-drug Conjugates Revenue by Application (2020-2025) (USD Million)
Table 107. United States Antibody-drug Conjugates Revenue Market Share by Application (2020-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
Table 111. Customers of Antibody-drug Conjugates
Table 112. Market Opportunities in Next Few Years
Table 113. Market Risks Analysis
Table 114. Market Drivers
List of Figures
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Adcetris Picture
Figure 4. Kadcyla Picture
Figure 5. Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 6. Breast Cancer Picture
Figure 7. Lymphoma Picture
Figure 8. Global Antibody-drug Conjugates Market Status and Outlook (2015-2025) (USD Million)
Figure 9. Global Antibody-drug Conjugates Sales Growth Rate (2015-2025) (Kg)
Figure 10. Global Antibody-drug Conjugates Sales Market Share by Manufacturer in 2019
Figure 11. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2019
Figure 12. Key Players Antibody-drug Conjugates Revenue Market Share in United States in 2019
Figure 13. Global Top 5 Antibody-drug Conjugates Manufacturer Market Share in 2019
Figure 14. Top 3 Antibody-drug Conjugates Players Market Share in United States in 2019
Figure 15. Global Antibody-drug Conjugates Revenue Market Share by Regions in 2019
Figure 16. North America Antibody-drug Conjugates Sales YoY Growth (2015-2025) (Kg)
Figure 17. North America Antibody-drug Conjugates Revenue YoY Growth (2015-2025) (USD Million)
Figure 18. Europe Antibody-drug Conjugates Sales YoY Growth (2015-2020) (Kg)
Figure 19. Europe Antibody-drug Conjugates Revenue YoY Growth (2015-2020) (USD Million)
Figure 20. Asia-Pacific Antibody-drug Conjugates Sales YoY Growth (2015-2020) (Kg)
Figure 21. Asia-Pacific Antibody-drug Conjugates Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. South America Antibody-drug Conjugates Sales YoY Growth (2015-2020) (Kg)
Figure 23. South America Antibody-drug Conjugates Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Middle East & Africa Antibody-drug Conjugates Sales YoY Growth (2015-2020) (Kg)
Figure 25. Middle East & Africa Antibody-drug Conjugates Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. North America Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 27. North America Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 28. United States Antibody-drug Conjugates Market Size and Growth Rate (2015-2025) (USD Million)
Figure 29. Canada Antibody-drug Conjugates Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Mexico Antibody-drug Conjugates Market Size and Growth Rate (2015-2020) (USD Million)
Figure 31. Europe Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 32. Germany Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 33. United Kingdom Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. France Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. Russia Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Italy Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region 2018
Figure 38. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Region 2018
Figure 39. China Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Japan Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Korea Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. India Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Southeast Asia Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Australia Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. South America Antibody-drug Conjugates Sales Market Share by Country in 2019
Figure 46. South America Antibody-drug Conjugates Revenue Market Share by Country in 2019
Figure 47. Brazil Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Argentina Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Saudi Arabia Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Turkey Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Egypt Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South Africa Antibody-drug Conjugates Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Global Revenue Market Share of Antibody-drug Conjugates by Type in 2019
Figure 54. Global Revenue Market Share of Antibody-drug Conjugates by Application in 2019
Figure 55. Sales Channel: Direct Channel vs Indirect Channel